Nosocomial Infection Treatment Market By Infection (Ventilator Associated Pneumonia, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, Gastrointestinal Infection, MRSA), By Treatment (Antibacterial Treatment, Antiviral Treatment, Antifungal Treatment) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

According to the WHO, nosocomial infection is defined as “an infection acquired in hospital by a patient who was admitted for a reason other than that infection”. An infection occurring in a patient in a hospital or other health care facility in whom the infection was not present or incubating at the time of admission. This includes infections acquired in the hospital but appearing after discharge, and also occupational infections among staff of the facility. The infection is caused due to bacteria, viruses, fungi and parasites. All hospital patients are susceptible to contract infection especially pediatric and geriatric section and immune compromised patient, due to extended stay in hospital, usage of indwelling catheters, some failure of health care provider or over dosage of antibiotics. The global nosocomial infection treatment market is anticipated to progress during the forecast period due to rising prevalence of nosocomial infections, increase in number of surgical procedures, and escalating focus on disinfection and sterilization technology.

The report titled “Global Nosocomial Infection Treatment Market - Growth, Share, Opportunities and Competitive Analysis, 2016–2024” offers strategic insights into the overall nosocomial infection treatment market along with the market size and estimates for the duration 2014 to 2024. The study covers in-depth analysis of multiple market segments based on type of product and different geographies. The infection types studied for analyzing the overall nosocomial infection treatment market is majorly segmented into ventilator associated pneumonia, urinary tract infection, blood stream infection, surgical site infection, MRSA and others. The treatment types considered for analyzing the market are antibacterial, antifungal, antiviral treatments and others.

Geographically, the Global Nosocomial Infection Treatment market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2014-2024. Market growth rates for the forecast period 2016-2024 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global nosocomial infection treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global nosocomial infection treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global nosocomial infection treatment market. In-depth competitive environment analysis and historical years market size data are also provided in the report.

Nosocomial Infection Treatment Market

Geographically, the global nosocomial infection treatment market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Nosocomial Infection Treatment Market

North America currently dominates the regional global nosocomial infection market followed by Europe. The key drivers for North America market are rising prevalence of nosocomial infection, multi-drug resistant microbes, and rising demand for advanced therapeutics. The U.S is the major market in North America due to incessant technological advancements in surgical procedures, sterilization equipment and state of art health care facilities. Europe is the second largest market attributed to rise in geriatric population which is prone to nosocomial infection, government initiative to improve the healthcare facility and advancement in antimicrobial therapeutics. Asia Pacific is the fastest growing market due to factors such as increasing investment in health care facilities, rise in per capita income fueled with economic development, huge government investments in development of healthcare infrastructure, rising public awareness coupled with high prevalence of nosocomial infection.

Choose License Type
Published Date:  Feb 2017
Category:  Pharmaceuticals
Report ID:   58358
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Connect With Us
24/7 Research Support